Related references
Note: Only part of the references are listed.Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy
Seuk-Min Ryu et al.
NATURE BIOTECHNOLOGY (2018)
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
Johnny H. Hu et al.
NATURE (2018)
Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
Nicole M. Gaudelli et al.
NATURE (2017)
Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
Brett T. Staahl et al.
NATURE BIOTECHNOLOGY (2017)
Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing
Hao Yin et al.
NATURE BIOTECHNOLOGY (2017)
Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer
Kevin P. O'Rourke et al.
NATURE BIOTECHNOLOGY (2017)
Highly efficient RNA-guided base editing in mouse embryos
Kyoungmi Kim et al.
NATURE BIOTECHNOLOGY (2017)
RNA editing with CRISPR-Cas13
David B. T. Cox et al.
SCIENCE (2017)
R-Spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine
Teng Han et al.
NATURE COMMUNICATIONS (2017)
Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery
Holly A. Rees et al.
NATURE COMMUNICATIONS (2017)
mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer
Tetsuo Mashima et al.
ONCOTARGET (2017)
Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T: A base editors with higher efficiency and product purity
Alexis C. Komor et al.
SCIENCE ADVANCES (2017)
Rescue of high-specificity Cas9 variants using sgRNAs with matched 5′ nucleotides
Sojung Kim et al.
GENOME BIOLOGY (2017)
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland
Stefano Annunziato et al.
GENES & DEVELOPMENT (2016)
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Alexis C. Komor et al.
NATURE (2016)
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver et al.
NATURE (2016)
Targeted AIDID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells
Yunqing Ma et al.
NATURE METHODS (2016)
Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells
Gaelen T. Hess et al.
NATURE METHODS (2016)
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
Keiji Nishida et al.
SCIENCE (2016)
Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses
Dan Wang et al.
HUMAN GENE THERAPY (2015)
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Benjamin P. Kleinstiver et al.
NATURE (2015)
Inducible in vivo genome editing with CRISPR-Cas9
Lukas E. Dow et al.
NATURE BIOTECHNOLOGY (2015)
Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids
Mami Matano et al.
NATURE MEDICINE (2015)
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Shengdar Q. Tsai et al.
NATURE BIOTECHNOLOGY (2015)
Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases
Sangsu Bae et al.
BIOINFORMATICS (2014)
Inhibiting Tankyrases Sensitizes KRAS-Mutant Cancer Cells to MEK Inhibitors via FGFR2 Feedback Signaling
Marie Schoumacher et al.
CANCER RESEARCH (2014)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
A pipeline for the generation of shRNA transgenic mice
Lukas E. Dow et al.
NATURE PROTOCOLS (2012)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
New targets of β-catenin signaling in the liver are involved in the glutamine metabolism
A Cadoret et al.
ONCOGENE (2002)